T&L Co., Ltd. (KOSDAQ:340570)

Market Cap	505.88B -13.8%
Revenue (ttm)	164.16B -6.1%
Net Income	38.07B -18.0%
EPS	4,725.38 -17.8%
Shares Out	8.02M
PE Ratio	13.35
Forward PE	8.95
Dividend	1,500.00 (2.38%)
Ex-Dividend Date	Dec 29, 2025

Volume	52,911
Average Volume	73,555
Open	63,000
Previous Close	63,100
Day's Range	60,550 - 63,000
52-Week Range	43,100 - 74,800
Beta	0.33
RSI	57.85
Earnings Date	May 14, 2026

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 242
• Stock Exchange: KOSDAQ
• Ticker Symbol: 340570

Financial Performance

In 2025, T&L Co., Ltd.'s revenue was 164.16 billion, a decrease of -6.14% compared to the previous year's 174.89 billion. Earnings were 38.07 billion, a decrease of -17.96%.